Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464607
Status:
COMPLETED
Last Update Posted:
2007-04-23
First Post:
2007-04-20
Brief Title:
Prospective Randomized Controlled Clinical Study on Tolerability and Efficacy of hMG-IBSA
Sponsor:
IBSA Institut Biochimique SA
Organization:
IBSA Institut Biochimique SA
Study Overview
Official Title:
A Prospective Randomized Controlled Clinical Study on the Assessment of Tolerability and of Clinical Efficacy of MERIONAL hMG-IBSA Administered Subcutaneously Versus MERIONALâ Administered Intramuscularly in Women Undergoing Controlled Ovarian Hyperstimulation COH in an ART Programme IVF
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose of the study is the evaluation of the tolerability both local and systemic and the clinical efficacy in terms oocytes recovered of subcutaneously versus intramuscularly administered Merional IBSA Lugano - CH in patients undergoing controlled ovarian hyperstimulation COH in an ART programme IVF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None